Nymox Pharmaceutical Corp. sell StockNews.com
Start price
25.06.23
/
50%
€0.29
Target price
25.06.24
-
Performance (%)
-21.77%
End price
26.06.24
-
Summary
This prediction is currently being closed. The prediction for Nymox Pharmaceutical Corp. shows a convincing performance of -21.77%. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Nymox Pharmaceutical Corp. | - | - | - |
iShares Core DAX® | -1.114% | 3.430% | 25.966% |
iShares Nasdaq 100 | 1.816% | 6.911% | 30.390% |
iShares Nikkei 225® | 2.113% | 5.501% | 23.404% |
iShares S&P 500 | 2.038% | 5.327% | 30.881% |
Comments by StockNews_com for this prediction
In the thread Nymox Pharmaceutical Corp. diskutieren
Nymox Pharmaceutical Co. (NASDAQ: NYMX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for NYMX provided by MarketBeat
In the thread Trading Nymox Pharmaceutical Corp.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Nymox Pharmaceutical Corp.
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.35
17.06.23
17.06.23
-
17.06.24
17.06.24
-33.91%
18.06.24
18.06.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.43
30.04.23
30.04.23
-
30.04.24
30.04.24
-47.00%
01.05.24
01.05.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.41
22.04.23
22.04.23
-
22.04.24
22.04.24
-43.90%
23.04.24
23.04.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
05.03.23
05.03.23
-
05.03.24
05.03.24
-35.75%
06.03.24
06.03.24
Nymox Pharmaceutical Corp.
Start price
Target price
Perf. (%)
€0.36
26.02.23
26.02.23
-
26.02.24
26.02.24
-35.75%
27.02.24
27.02.24